Top Markets
#1 Islamic Coin Islamic Coin +151.53%
#2 Palladium Network Palladium Network +18.73%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.95%
#4 clBTC clBTC +12.16%
#5 OpenEden OpenEden +10.74%
#6 Not in Employment, Education, or Training Not in Employment, Education, or Training +9.75%
#7 Wrapped Ether (Mantle Bridge) Wrapped Ether (Mantle Bridge) +8.73%
#8 MarsCoin MarsCoin +8.66%
#9 Mantle Staked Ether Mantle Staked Ether +8.33%
#10 Mantle Restaked ETH Mantle Restaked ETH +8.01%
Coin of the day
Islamic Coin Islamic Coin
Instellingen
Taal
DUTCH
Valuta
USD
Thema
The Greater Cannabis Company, Inc. The Greater Cannabis Company, Inc.

The Greater Cannabis Company, Inc.

GCAN
Rang in aandelen #40153
The Greater Cannabis Company, Inc. engages in the development and... The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland.
Aandeelprijs
$0.2301
Laatst gesynchroniseerd: 2026-08-12
Marktkapitalisatie
$228.81K
Verandering (1 dag)
-17.82%
Verandering (1 jaar)
95,775.00%
Land
US
Handel The Greater Cannabis Company, Inc. (GCAN)

Categorie

Healthcare
Dividendrendementgeschiedenis voor The Greater Cannabis Company, Inc. (GCAN)
Het dividendrendement (TTM) van The Greater Cannabis Company, Inc. (aandelsymbool: GCAN) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van The Greater Cannabis Company, Inc. (GCAN) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
1.56%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
0.00%
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
0.00%
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
0.00%
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
0.00%
US